References and Notes
1a
Kozikowski AP.
Acc. Chem. Res.
1984,
17:
410
1b
Baraldi PG.
Barco A.
Benetti S.
Pollini GP.
Simoni D.
Synthesis
1987,
857
1c
Litvinovskaya RP.
Khripach VA.
Russ. Chem. Rev. (Engl. Transl.)
2001,
70:
405
1d
Kotyatkina AI.
Zhabinsky VN.
Khripach VA.
Russ. Chem. Rev. (Engl. Transl.)
2001,
70:
641
For selected recent examples, see:
2a
Itoh T.
Watanabe M.
Fukuyama T.
Synlett
2002,
1323
2b
Lemaire M.
Veny N.
Gefflaut T.
Gallienne E.
Chênevert R.
Bolte J.
Synlett
2002,
1359
2c
Li S.
Donaldson WA.
Synthesis
2003,
2064
2d
Fuller AA.
Chen B.
Minter AR.
Mapp AK.
Synlett
2004,
1409
2e
Sewald N.
Angew. Chem. Int. Ed.
2003,
42:
5794
2f
Muri D.
Lohse-Fraefel N.
Carreira EM.
Angew. Chem. Int. Ed.
2005,
44:
4036
2g
Zimmermann PJ.
Lee JY.
Hlobilova (née Blanarikova) I.
Endermann R.
Häbich D.
Jäger V.
Eur. J. Org. Chem.
2005,
3450
2h
Fleming KN.
Taylor RE.
Angew. Chem. Int. Ed.
2004,
43:
1728
3a
Antczak C.
Bauvois B.
Monneret C.
Florent J.-C.
Bioorg. Med. Chem.
2001,
9:
2843
3b
Olson RE.
Sielecki TM.
Wityak J.
Pinto DJ.
Batt DG.
Frietze WE.
Liu J.
Tobin AE.
Orwat MJ.
Di Meo SV.
Houghton GC.
Lalka GK.
Mousa SA.
Racanelli AL.
Hausner EA.
Kapil RP.
Rabel SR.
Thoolen MJ.
Reilly TM.
Anderson PS.
Wexler RR.
J. Med. Chem.
1999,
42:
1178
3c
Alcázar J.
Alonso JM.
Andrés JI.
Bartolomé JM.
Fernández J.
Synlett
2005,
3139
4
Arai MA.
Kuraishi M.
Arai T.
Sasai H.
J. Am. Chem. Soc.
2001,
123:
2907
5a
Mukaiyama T.
Hoshino T.
J. Am. Chem. Soc.
1960,
82:
5339
5b
Vigalok IV.
Moisak IE.
Svetlakov NV.
Chem. Heterocycl. Compd.
1969,
5:
133 ; Khim. Geterotsikl. Soedin
1969, 5, 175; Chem. Abstr.
1969, 71, 3330
5c
McMurry JE.
Org. Synth.
1973,
53:
59
5d
Harada K.
Kaji E.
Sen S.
Chem. Pharm. Bull.
1980,
28:
3296
5e
Jäger V.
Müller I.
Tetrahedron
1985,
41:
3519
5f
Basel Y.
Hassner A.
Synthesis
1997,
309
5g
Maugein N.
Wagner A.
Mioskowsi C.
Tetrahedron Lett.
1997,
38:
1547
5h
Giacomelli G.
De Luca L.
Porcheddu A.
Tetrahedron
2003,
59:
5437
6a
Cecchi L.
De Sarlo F.
Machetti F.
Tetrahedron Lett.
2005,
46:
7877
6b
Cecchi L.
De Sarlo F.
Faggi C.
Machetti F.
Eur. J. Org. Chem.
2006,
3016
6c
Cecchi L.
De Sarlo F.
Machetti F.
Eur. J. Org. Chem.
2006,
4852
6d
Machetti F.
Cecchi L.
Trogu E.
De Sarlo F.
Eur. J. Org. Chem.
2007,
4352
7
Snider BB.
Che Q.
Tetrahedron
2002,
58:
7821
8
Warsinsky R.
Steckhan E.
J. Chem. Soc., Perkin Trans. 1
1994,
2027
9
Typical Procedure for the Catalysed Condensation of 1-Nitropentane and Methyl Acrylate
Copper(II) acetate (3.9 mg, 0.021 mmol) was treated with a solution of nitropentane (124 mg, 1.06 mmol), methyl acrylate (37 mg, 0.42 mmol), and 1-methylpiperidine (21 mg, 0.21 mmol) in CHCl3 (1.4 mL) and the mixture magnetically stirred in a sealed vessel (Schlenk) at 60 °C. After 40 h the reaction mixture was concentrated and the residue dissolved in EtOAc (15 mL) and washed with 5% HCl (3 × 15 mL portions), sat. Na2CO3 (3 × 15 mL portions), and brine (3 × 15 mL portions). The organic layer was dried (Na2SO4), filtered, and concentrated. The residue was purified by chromatography on silica gel eluting first with hexane and then with hexane-Et2O (4:3). The isoxazoline [R
f
(hexane-Et2O) = 0.22, 71 mg] was obtained as a clear oil in 90% yield.
Analytical Data
1H NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.6 Hz, 3 H, CH
3), 1.29-1.41 (m, 2 H, CH
2CH3), 1.48-1.59 (m, 2 H, CH
2CH2C-3), 2.35 (t, J = 8.0 Hz, 2 H, CH2C-3), 3.19 (d, J = 9.0 Hz, 2 H, 4-H), 3.76 (s, 3 H, OCH3), 4.96 (t, J = 9.0 Hz, 1 H, 5-H) ppm. 13C NMR (100.58 MHz, CDCl3): δ = 13.6 (q, CH3), 22.2 (t, CH2CH3), 26.8 (t, CH2C-3), 28.3 (t, CH2CH2CH3), 40.8 (t, C-4), 52.6 (q, OCH3), 76.8 (d, C-5), 158.4 (s, C-3), 171.0 (s, C=O) ppm. MS (EI, 70 eV): m/z (%) = 185 (<1) [M]+, 143 (23), 126 (12) [M - CO2Me]+, 98 (20), 57 (100). IR (CDCl3): 1739 (C=O), 1622 (C=N) cm-1. Anal. Calcd for C9H15NO3 (185.22): C, 58.36; H, 8.16; N, 7.56. Found: C, 58.19; H, 8.43; N, 7.89.
10
Torssell KBG.
Nitrile Oxides, Nitrones, Nitronates in Organic Synthesis
VCH Publishers;
New York:
1988.
p.55
11
McKillop A.
Kobylecki RJ.
Tetrahedron
1974,
30:
1365